Clinical Trials Logo
  1. Home
  2. PAD
  3. NCT01260870
  4. Details
NCT01260870 Clinical Trial

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

PAD Clinical Trial

Official title:
European Study of POBA Versus Cotavance Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT01260870
Other study ID # EURO CANAL
Secondary ID
Status Terminated
Phase Phase 2
First received
Last updated
Start date August 15, 2011
Est. completion date July 15, 2013

Study information
Verified date January 2024
Source Bayer
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the procedural safety and to identify and characterize therapeutic and functional endpoint assessments in subjects with documented critical limb ischemia who received treatment with the Cotavance Paclitaxel-Coated Balloon vs. those who received POBA only.

Recruitment information / eligibility
Status Terminated
Enrollment 44
Est. completion date July 15, 2013
Est. primary completion date July 15, 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subjects with CLI Exclusion Criteria: - Participation in another research trial - Medical conditions the study doctor will assess

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Cotavance Paclitaxel Coated Balloon

• Standard balloon angioplasty

Locations
Country Name City State
Austria Medical University Graz
Belgium AZ St.-Blasius Hospital Dendermonde
Belgium University Hospital Gent
Switzerland University Hospital Bern
Switzerland University Hospital Zurich
United Kingdom St. George's Hospital London

Sponsors (1)
Lead Sponsor Collaborator
Bayer

Countries where clinical trial is conducted

Austria,  Belgium,  Switzerland,  United Kingdom, 

Outcome
Type Measure Description Time frame Safety issue
Primary Evaluate procedural safety 30 days
Secondary Identify and characterize therapeutic and functional endpoint assessments 5 years
See also
  Status Clinical Trial Phase
Completed NCT03157531 - Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PAD N/A
Recruiting NCT03668353 - Recombinant SeV-hFGF2/dF Injection for PAOD Phase 1
Not yet recruiting NCT04108806 - Study of Peripheral Arterial Calcification N/A
Completed NCT02561299 - Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study N/A
Completed NCT01355406 - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System N/A
Recruiting NCT06239493 - IVUS-Guided Treatment for Percutaneous Vascular Interventions
Active, not recruiting NCT00390767 - Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) Phase 1/Phase 2
Completed NCT02907203 - Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
Recruiting NCT03686228 - Treatment of No-option CLI by G-CSF-mobilized PB-MNC N/A
Recruiting NCT03683628 - Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC N/A
Active, not recruiting NCT04204564 - VISION and VQI Paclitaxel Safety Analysis
Terminated NCT01341340 - The ABSORB BTK (Below The Knee) Clinical Investigation N/A
Completed NCT03135535 - Micro-mobile Foot Compression and Diabetic Foot Phase 2
Recruiting NCT03900832 - Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability Early Phase 1
Completed NCT03452293 - SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
Recruiting NCT05361967 - Tack Optimized Balloon Angioplasty Post-Market Study
Active, not recruiting NCT02500303 - Influence of Diabetes on Lower Limb Amputation N/A
Completed NCT03358355 - Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial Phase 1/Phase 2
Withdrawn NCT03516383 - Pulse Wave Velocity Imaging in the Assessment of PAD
Completed NCT03590769 - Arterial Imaging of Inflammation and Resolution After Endovascular Surgery Phase 1